Table 1.
Brain Region | Main Effect of Tat | Tat/DOX Duration | Interaction | ||||
---|---|---|---|---|---|---|---|
PFC | Chemokine | F(1,34) | p | F(2,34) | p | F(2,34) | p |
CCL2 | 2.96 | 0.95 | 14.35 | <0.01# | 2.95 | 0.07 | |
CCL3 | 0.01 | 0.91 | 16.24 | <0.01# | 3.41 | 0.04 | |
CCL4 | 6.48 | 0.02 | 29.46 | <0.01# | 1.20 | 0.32 | |
CCL5 | 0.78 | 0.38 | 213.80 | <0.01# | 0.54 | 0.59 | |
CCL11 | 1.36 | 0.25 | 101.90 | <0.01# | 0.12 | 0.89 | |
CXCL1 | 6.06 | 0.02 | 1.49 | 0.24 | 1.72 | 0.19 | |
G-CSF | 5.03 | 0.03 | 2.00 | 0.15 | 1.27 | 0.29 | |
GM-CSF | 0.72 | 0.40 | 13.47 | <0.01# | 0.38 | 0.69 | |
Striatum | Chemokine | F(1,32) | p | F(2,32) | p | F(2,32) | p |
CCL2 | 0.06 | 0.80 | 13.12 | <0.01# | 2.09 | 0.14 | |
CCL3 | 0.12 | 0.73 | 3.98 | 0.03‡ | 2.51 | 0.10 | |
CCL4 | 1.76 | 0.19 | 0.22 | 0.80 | 2.25 | 0.12 | |
CCL5 | 4.17 | 0.05 | 0.32 | 0.73 | 0.62 | 0.55 | |
CCL11 | 5.94 | 0.02 | 8.96 | <0.01# | 0.85 | 0.44 | |
CXCL1 | 0.51 | 0.48 | 2.56 | 0.09 | 1.90 | 0.17 | |
G-CSF | 0.22 | 0.64 | 18.52 | <0.01@‡ | 0.27 | 0.77 | |
GM-CSF | 1.20 | 0.28 | 1.55 | 0.23 | 1.77 | 0.19 | |
Thalamus | Chemokine | F(1,31) | p | F(2,31) | p | F(2,31) | p |
CCL2 | 0.17 | 0.68 | 35.20 | <0.01#‡ | 0.37 | 0.70 | |
CCL3 | 0.00 | 0.98 | 0.84 | 0.44 | 0.45 | 0.64 | |
CCL4 | 0.56 | 0.46 | 1.95 | 0.16 | 0.50 | 0.61 | |
CCL5 | 5.25 | 0.03 | 191.00 | <0.01$ | 1.64 | 0.21 | |
CCL11 | 0.57 | 0.46 | 985.20 | <0.01+‡ | 3.16 | 0.06 | |
CXCL1 | 0.23 | 0.64 | 21.45 | <0.01# | 0.24 | 0.79 | |
G-CSF | 0.46 | 0.50 | 26.13 | <0.01$ | 0.18 | 0.83 | |
GM-CSF | 0.13 | 0.72 | 33.76 | <0.01$ | 0.05 | 0.95 |
The F-values, degrees of freedom, and P-values from the chemokine ANOVA results. Bolded values denote significant differences at α = 0.05 (Bonferroni correction for multiple comparisons). Main effect of exposure time within each separate region, $ All exposure time-points (48 h, 2-week, and 8-week) are significantly different, # 48 h exposure time-point significantly differs from respective 2- and 8-week DOX exposure time-points; @ 48 h exposure time-point differs from the respective 2-week exposure time-point; + 48 h exposure time-point differs from its respective 8-week exposure time-point; ‡ 2-week exposure time-point differs from the respective 8-week exposure time-point.